Literature DB >> 26732157

Ketonemia and ketonuria in gestational diabetes mellitus.

Loukia Spanou1, Kalliopi Dalakleidi2, Konstantia Zarkogianni2, Anastasia Papadimitriou1, Konstantina Nikita1, Vasiliki Vasileiou1, Maria Alevizaki1, Eleni Anastasiou1.   

Abstract

BACKGROUND: The use of capillary blood 3-β-hydroxybutyrate (3HB) is a more precise method than urine ketones measurement for the diagnosis of diabetic ketoacidosis. Fasting ketonuria is common during normal pregnancy, while there is evidence that it is increased among pregnant women with Gestational Diabetes Mellitus (GDM) who are on a diet. 3HB levels have been related to impaired offspring psychomotor development. Reports with concomitant measurement of blood and urine ketones in women with GDM who followed a balanced diet are lacking.
OBJECTIVE: To compare the prevalence of fasting ketonemia and ketonuria in women with GDM following the Institute of Medicine diet instructions and assess their possible relation with metabolic parameters and therapeutic interventions. RESEARCH DESIGN AND METHODS: 180 women with GDM were studied. In each patient, in successive visits, capillary blood and urine ketones were simultaneously measured. The total measurements were 378, while the average number of measurements per patient was 2.1.
RESULTS: The prevalence of ketonuria was significantly higher than that of ketonemia (x(2)=21.33, p <0.001). Significantly higher mean 3HB levels were observed with respect to ketonuria severity (p=0.001). Bedtime carbohydrate intake was associated with significantly lower 3HB levels (p=0.035). Insulin treatment was associated with significant 3HB levels reduction (p=0.032). Body weight reduction per week between two serial visits was associated with increased 3HB levels (p=0.005). Multiple linear regression analysis showed that weight loss remained the only independent predictor of 3HB levels.
CONCLUSIONS: The presence of ketonemia was significantly lower than the presence of ketonuria. Weight loss per week was the only independent factor found to be associated with increased levels of 3HB. The clinical significance of this small increase requires further investigation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26732157     DOI: 10.14310/horm.2002.1610

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  6 in total

Review 1.  Pregnancy Ketonemia and Development of the Fetal Central Nervous System.

Authors:  Agata Bronisz; Mateusz Ozorowski; Magdalena Hagner-Derengowska
Journal:  Int J Endocrinol       Date:  2018-06-04       Impact factor: 3.257

2.  Lactobacillus bulgaricus improves antioxidant capacity of black garlic in the prevention of gestational diabetes mellitus: a randomized control trial.

Authors:  Lihui Si; Ruixin Lin; Yan Jia; Wenwen Jian; Qing Yu; Min Wang; Shuli Yang
Journal:  Biosci Rep       Date:  2019-08-09       Impact factor: 3.840

Review 3.  Effect of Elevated Ketone Body on Maternal and Infant Outcome of Pregnant Women with Abnormal Glucose Metabolism During Pregnancy.

Authors:  Meichen Qian; Na Wu; Ling Li; Wenshu Yu; Hong Ouyang; Xinyan Liu; Yujing He; Abdulrahman Al-Mureish
Journal:  Diabetes Metab Syndr Obes       Date:  2020-11-25       Impact factor: 3.168

4.  Effects of intermittently scanned continuous glucose monitoring on blood glucose control and the production of urinary ketone bodies in pregestational diabetes mellitus.

Authors:  Shu-Ying Li; Hang Guo; Yi Zhang; Pei Li; Pei Zhou; Li-Rong Sun; Jing Li; Li-Ming Chen
Journal:  Diabetol Metab Syndr       Date:  2021-04-09       Impact factor: 3.320

5.  Test validation, method comparison and reference range for the measurement of β-hydroxybutyrate in peripheral blood samples.

Authors:  Frank Bernhard Kraus; Marija Kocijancic; Alexander Kluttig; Beatrice Ludwig-Kraus
Journal:  Biochem Med (Zagreb)       Date:  2020-02-15       Impact factor: 2.313

6.  Nutrition for Gestational Diabetes-Progress and Potential.

Authors:  Clive J Petry
Journal:  Nutrients       Date:  2020-09-03       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.